Infectious disease outbreaks, such as measles, HIV, and mpox, expose critical vulnerabilities across public health systems.

Adults aged 18 to 64 years with high-risk conditions demonstrate higher rates of RSV-related LRTD than those without these conditions.

A study of insured US patients shows that oseltamivir is the primary influenza antiviral, while inpatient use of peramivir continues to grow.

Infectious Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve ...

Real-time electronic health record alerts significantly increase chlamydia screening orders in primary care settings, highlighting the utility of integrating targeted digital prompts into clinical ...

For patients with axial spondyloarthritis, bimekizumab, a dual interleukin (IL)-17A and IL-17F inhibitor, is well tolerated over 3 years.

The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.

Vaccine effectiveness varied across different age demographics and virus strains, offering the highest protection against influenza B and among children and adolescents during the 2024-2025 season, ...

Live attenuated measles-mumps-rubella and varicella vaccines are not associated with an increased risk for multiple sclerosis disease relapse.

Infections, not eosinophilic inflammation, are the primary cause of asthma exacerbations in patients receiving benralizumab.